Clinical trials
Phase 1 Triple Negative Breast Neoplasms trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
| Active, not recruiting | 6 |
| Completed | 6 |
| Terminated | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 8 |
| AbbVie | 5 |
| Eli Lilly and Company | 5 |
| Alterome Therapeutics, Inc. | 1 |
| AstraZeneca | 1 |
| Bayer | 1 |
| Daiichi Sankyo Co., Ltd. | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
| SystImmune Inc. | 1 |
| Volastra Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 25 |
| Carcinoma, Non-Small-Cell Lung | 15 |
| Ovarian Neoplasms | 10 |
| Squamous Cell Carcinoma of Head and Neck | 10 |
| Neoplasm Metastasis | 7 |
| Carcinoma, Hepatocellular | 6 |
| Esophageal Neoplasms | 6 |
| Neoplasms | 6 |
| Stomach Neoplasms | 6 |
| Uterine Cervical Neoplasms | 6 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.